Cancers
Overview
Cancers is a peer-reviewed open-access journal that focuses on all aspects of cancer research, including molecular biology, genetics, immunology, and clinical studies. It provides a platform for scientists and clinicians to share their latest findings and advancements in understanding cancer development, diagnosis, treatment, and prevention. With its multidisciplinary approach, Cancers aims to contribute to the global effort in combating this complex and devastating disease.
Details
Details
Abbr.
Cancers (Basel)
Publisher
MDPI
Start
2009
End
Continuing
Frequency
Quarterly
e-ISSN
2072-6694
Country
Switzerland
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 1831
133
SJR / Ranks: 2212
1391
CiteScore / Ranks: 2600
7.40
JIF / Ranks: 1476
5.2
Recent Articles
1.
2.
Rizzo G, Coluccio C, Forti E, Fugazza A, Binda C, Vanella G, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075757
This multicenter retrospective study included patients undergoing EUS-guided GI anastomoses from 2016 to 2023. Indications for EUS-guided anastomosis were GOO, ALS or patients with altered anatomy needing endoscopic interventions. The...
3.
Jang Y
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075756
Dihydroceramide (dhCer) was previously considered an inactive precursor of ceramide, a well-known sphingoid base involved in regulating apoptosis and cell death. However, recent studies have shown that dhCer plays a...
4.
Volpe S, Vincini M, Zaffaroni M, Gaeta A, Raimondi S, Piperno G, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075755
An Early-Stage Non-Small Cell Lung Cancer (ES-NSCLC) patient candidate for stereotactic body radiotherapy (SBRT) may start their treatment without a histopathological assessment, due to relevant comorbidities. The aim of this...
5.
Maher N, Mouhssine S, Matti B, Alwan A, Gaidano G
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075754
Histological transformation (HT) into aggressive lymphoma is a turning point in a significant fraction of patients affected by indolent lymphoproliferative neoplasms, namely, chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), marginal...
6.
Roussot N, Kaderbhai C, Ghiringhelli F
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075753
Non-small-cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide. Immunotherapy targeting the PD-1/PD-L1 axis has revolutionized treatment, providing durable responses in a subset of patients. However, with...
7.
Pundavela J, Hall A, Dinglasan S, Choi K, Rizvi T, Trapnell B, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075752
Plexiform neurofibroma (PNF) is an immune cell-rich peripheral nerve sheath tumor that develops primarily in individuals with Neurofibromatosis Type 1 (NF1). Granulocyte-macrophage colony stimulating factor receptor-β (GM-CSFR-β) is a shared...
8.
Tsolakidis D, Kyziridis D, Panoskaltsis T, Kalakonas A, Theodoulidis V, Chatzistamatiou K, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075751
Hyperthermic intraperitoneal chemotherapy (HIPEC) was revealed as a promising adjunct to cytoreductive surgery (CRS) in the treatment of advanced epithelial ovarian cancer (EOC). This review evaluated the impact HIPEC had...
9.
Talubo N, Dela Cruz E, Fowler P, Tsai P, Tayo L
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075750
: The molecular heterogeneity and metabolic flexibility of Hepatocellular Carcinoma (HCC) pose significant challenges to the efficacy of systemic therapy for advanced cases. Early screening difficulties often delay diagnosis, leading...
10.
Jo S, Kim J
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075749
Prostate cancer is one of the most commonly diagnosed malignancies worldwide and is a major cause of cancer-associated morbidity in men. Radical prostatectomy (RP) is a cornerstone of intervention for...